Filing Details

Accession Number:
0001093557-16-000416
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-13 20:43:31
Reporting Period:
2016-01-11
Filing Date:
2016-01-13
Accepted Time:
2016-01-13 20:43:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343856 A Jorge Valdes 6340 Sequence Drive
San Diego CA 92121
Cto No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-01-11 1,641 $78.43 5,631 No 4 S Indirect by Trust
Common Stock Disposition 2016-01-12 5,610 $80.16 21 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 92,437 Direct
Footnotes
  1. On November 9, 2015 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $77.45 to $80.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
  4. This transaction was executed in multiple trades at prices ranging from $79.00 to $81.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.